Abiraterone induces SLCO1B3 expression in prostate cancer via microRNA-579-3p

Abstract Understanding mechanisms of resistance to abiraterone, one of the primary drugs approved for the treatment of castration resistant prostate cancer, remains a priority. The organic anion polypeptide 1B3 (OATP1B3, encoded by SLCO1B3) transporter has been shown to transport androgens into pros...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Roberto H. Barbier, Edel M. McCrea, Kristi Y. Lee, Jonathan D. Strope, Emily N. Risdon, Douglas K. Price, Cindy H. Chau, William D. Figg
Format: article
Langue:EN
Publié: Nature Portfolio 2021
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/e06fd1fa19174341a92b77d01fce5e9c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!